This finding is in agreement both with the correlation found between active Akt and active p65 in biopsies from melanoma patients [68] and with the observed deactivation of NF-κB upon Akt inhibition seen in several tumor types, including melanoma [68,69,70]. The gene discussed is NFKB1; the disease is neoplasm.